Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangpeng Li

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Analytical and Bioanalytical Chemistry|December 8, 2017
Microfluidic systems for studying dynamic function of adipocytes and adipose tissueXiangpeng Li, Christopher J Easley
Medicine|January 10, 2026
Comparative safety profiling of sodium zirconate cyclosilicate and patiromer using real-world FAERS data: A pharmacovigilance analysisLianhao Fu, Haonan Liang, Xiangpeng Li
Lab on a Chip|August 17, 2018
Automated microfluidic droplet sampling with integrated, mix-and-read immunoassays to resolve endocrine tissue secretion dynamicsXiangpeng Li, Juan Hu, Christopher J Easley
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 18, 2012
Stereoselective synthesis of fully protected (2S,4S,6S)-2-amino-6-hydroxy-4-methyl-8-oxodecanoic acid (AHMOD)Wei Zhang, Xiangpeng Li, Ning Ding, et al.
Infection and Drug Resistance|August 5, 2021
Combination Therapy of Polymyxin B and Amikacin for Community-Acquired <i>Pseudomonas aeruginosa</i> Pneumonia with MODS in a Previously Healthy Patient: A Case ReportJunyu Wang, Lu Yun, Hong Zhao, et al.
The Journal of Organic Chemistry|April 25, 2008
Efficient synthesis of a sialic acid alpha(2-->3)galactose building block and its application to the synthesis of ganglioside GM3Yunpeng Liu, Xiaohong Ruan, Xiangpeng Li, et al.
Plos One|October 10, 2025
Safety assessment of obinutuzumab: Real-world adverse event analysis based on the FAERS and JADER databases from 2013 to 2025Xiangpeng Li, Haonan Liang, Ping Leng, et al.
Expert Opinion on Drug Safety|April 3, 2025
Adverse event signal analysis of type Ib MET tyrosine kinase inhibitors based on food and drug administration adverse event reporting systemJunyu Wang, Rong Ma, Binbin Qu, et al.
Iscience|January 9, 2026
Droplet microfluidics strategies for overcoming bottlenecks in antibiotics discoveryHassan Barakat, Makenzie Bolton, Jingjing Cheng, et al.
Frontiers in Pharmacology|November 14, 2024
The regulating role of galectin-9 in immune cell populationsZhanqi Cao, Ping Leng, Hanlin Xu, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Analytical and Bioanalytical Chemistry|December 8, 2017
Microfluidic systems for studying dynamic function of adipocytes and adipose tissueXiangpeng Li, Christopher J Easley
Medicine|January 10, 2026
Comparative safety profiling of sodium zirconate cyclosilicate and patiromer using real-world FAERS data: A pharmacovigilance analysisLianhao Fu, Haonan Liang, Xiangpeng Li
Lab on a Chip|August 17, 2018
Automated microfluidic droplet sampling with integrated, mix-and-read immunoassays to resolve endocrine tissue secretion dynamicsXiangpeng Li, Juan Hu, Christopher J Easley
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 18, 2012
Stereoselective synthesis of fully protected (2S,4S,6S)-2-amino-6-hydroxy-4-methyl-8-oxodecanoic acid (AHMOD)Wei Zhang, Xiangpeng Li, Ning Ding, et al.
Infection and Drug Resistance|August 5, 2021
Combination Therapy of Polymyxin B and Amikacin for Community-Acquired <i>Pseudomonas aeruginosa</i> Pneumonia with MODS in a Previously Healthy Patient: A Case ReportJunyu Wang, Lu Yun, Hong Zhao, et al.
The Journal of Organic Chemistry|April 25, 2008
Efficient synthesis of a sialic acid alpha(2-->3)galactose building block and its application to the synthesis of ganglioside GM3Yunpeng Liu, Xiaohong Ruan, Xiangpeng Li, et al.
Plos One|October 10, 2025
Safety assessment of obinutuzumab: Real-world adverse event analysis based on the FAERS and JADER databases from 2013 to 2025Xiangpeng Li, Haonan Liang, Ping Leng, et al.
Expert Opinion on Drug Safety|April 3, 2025
Adverse event signal analysis of type Ib MET tyrosine kinase inhibitors based on food and drug administration adverse event reporting systemJunyu Wang, Rong Ma, Binbin Qu, et al.
Iscience|January 9, 2026
Droplet microfluidics strategies for overcoming bottlenecks in antibiotics discoveryHassan Barakat, Makenzie Bolton, Jingjing Cheng, et al.
Frontiers in Pharmacology|November 14, 2024
The regulating role of galectin-9 in immune cell populationsZhanqi Cao, Ping Leng, Hanlin Xu, et al.
Pageof 7